Abstract

BackgroundEosinophils constitute 1%–5% of peripheral blood leukocytes, less in the presence of acute infections (referred to as eosinopenia). Studies indicate that eosinopenia can be used as a prognostic predictor for chronic obstructive pulmonary disease exacerbation, sepsis, or acute myocardial infarction disease. There are only a few studies about predicting mortality in emergency departments and intensive care units (ICUs). Prognostic studies about patients in ICUs are generally carried out using different scoring systems. We aimed to analyze if the eosinophil count can estimate the prognosis among non-traumatic patients who underwent cardiopulmonary resuscitation and were hospitalized in ICU thereafter.MethodsThe data were evaluated of 865 non-traumatic adult patients (>18 years of age) who were admitted with cardiopulmonary arrest or developed cardiopulmonary arrest during clinical follow-ups. Admission venous blood sample tests, complete blood count, and biochemical laboratory results were recorded. Arterial blood gas results were also evaluated. The mean results of the recorded laboratory results were compared between the surviving and non-surviving patients groups.ResultsThere was a significant difference between the two groups in regard to platelet, eosinophil count, pH, PaO2, SaO2, and HCO3− (P<0.001 for all). In the multiple linear regression analysis, eosinophil counts were found to be an independent factor (odds ratio=0.03, 95% confidence interval 0.33–0.56, P<0.001) associated with the mortality after cardiopulmonary resuscitation.ConclusionBecause admission eosinophil counts can be measured easily, they are inexpensive biomarkers that can be used for predicting the prognosis among the patients who have return of spontaneous circulation and are treated in ICUs.

Highlights

  • Eosinophils were first described by Paul Ehrlich in 1879.1 Constituting 1%–5% of the peripheral blood leukocytes, eosinophils represent up to 6% of the nucleated cells in bone marrow

  • There was a significant difference between the two groups in regard to platelet, eosinophil count, power of hydrogen (pH), partial pressure of oxygen in arterial blood (PaO2), partial arterial oxygen saturation (SaO2), and HCO3- (P

  • In the multiple linear regression analysis, eosinophil counts were found to be an independent factor associated with the mortality after cardiopulmonary resuscitation

Read more

Summary

Introduction

Eosinophils were first described by Paul Ehrlich in 1879.1 Constituting 1%–5% of the peripheral blood leukocytes, eosinophils represent up to 6% of the nucleated cells in bone marrow. Use of eosinopenia as a prognostic biomarker has been analyzed in chronic obstructive pulmonary disease exacerbation, sepsis, and acute myocardial infarction.[6,7,8] There are only a few studies regarding the use of eosinopenia to predict mortality in emergency departments and intensive care units (ICUs). Prognostic studies on ICU patients are carried out using various scoring systems.[9] Some studies have described different types of new biomarkers, including plasma Mg, high-mobility group protein B1, and urokinase-type plasminogen activator receptor, in the ongoing search for better tools for prognosis of mortality.[10,11,12]. We aimed to analyze if the eosinophil count can estimate the prognosis among non-traumatic patients who underwent cardiopulmonary resuscitation and were hospitalized in ICU thereafter

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call